Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Hikma Proves Resilient In 2020 Despite Some Bumpy Launches
Rivals To Advair And Vascepa Suffer From Delays And API Scarcity
Mar 01 2021
•
By
Dave Wallace
Hikma has come through turbulence in 2020 to report solid growth • Source: Shutterstock
More from Earnings
More from Business